These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 1535320)

  • 41. Effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) after repeated administration on a conditioned avoidance response (CAR) in the rat.
    Evenden JL
    Psychopharmacology (Berl); 1992; 109(1-2):134-44. PubMed ID: 1365647
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Suppression of conditioned avoidance by 8-OH-DPAT in the rat.
    Wadenberg ML; Ahlenius S
    J Neural Transm; 1988; 74(3):195-8. PubMed ID: 2974881
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The long-term effects of 8-hydroxy-2-(di-n-propyl-amino)tetralin (8-OH-DPAT) on copulatory and exploratory behaviour in male rats.
    Johansson CE; Meyerson BJ; Höglund AU
    Eur J Pharmacol; 1990 Mar; 178(1):1-9. PubMed ID: 2139613
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peripheral 8-OH-DPAT and scopolamine infused into the frontal cortex produce passive avoidance retention impairments in rats.
    Santucci AC; Shaw C
    Neurobiol Learn Mem; 2003 Mar; 79(2):136-41. PubMed ID: 12591222
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in monkeys.
    Mizuta E; Yamaguchi M; Kuno S
    Eur J Pharmacol; 1990 Mar; 178(1):125-7. PubMed ID: 2139614
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat.
    Calogero AE; Bagdy G; Szemeredi K; Tartaglia ME; Gold PW; Chrousos GP
    Endocrinology; 1990 Apr; 126(4):1888-94. PubMed ID: 2156670
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat.
    Dourish CT; Hutson PH; Curzon G
    Psychopharmacology (Berl); 1985; 86(1-2):197-204. PubMed ID: 3161115
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy.
    Wadenberg ML; Ahlenius S
    J Neural Transm Gen Sect; 1991; 83(1-2):43-53. PubMed ID: 1673344
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determination of the 5-HT receptor subtype involved in 8-OH-DPAT-induced hyperlocomotion: potential difficulties arising from inadequate pharmacological tools.
    Kalkman HO; Soar J
    Eur J Pharmacol; 1990 Dec; 191(3):383-90. PubMed ID: 2150821
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Para-chlorophenylalanine prevents feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT).
    Dourish CT; Hutson PH; Curzon G
    Psychopharmacology (Berl); 1986; 89(4):467-71. PubMed ID: 2428076
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Marked increases in plasma catecholamine concentrations precede hypotension and bradycardia caused by 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in conscious rats.
    Bagdy G; Szemeredi K; Murphy DL
    J Pharm Pharmacol; 1989 Apr; 41(4):270-2. PubMed ID: 2568470
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contractile effects of 8-hydroxy-2-(di-n-propylamino)tetralin and flesinoxan in human isolated basilar artery.
    Parsons AA; Motevalian M; Whalley ET
    Eur J Pharmacol; 1991 Sep; 202(1):17-23. PubMed ID: 1664803
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of hippocampal CaMKII in serotonin 5-HT(1A) receptor-mediated learning deficit in rats.
    Moyano S; Del Río J; Frechilla D
    Neuropsychopharmacology; 2004 Dec; 29(12):2216-24. PubMed ID: 15199370
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential responsiveness of the rat dorsal and median raphe 5-HT systems to 5-HT1 receptor agonists and p-chloroamphetamine.
    Blier P; Serrano A; Scatton B
    Synapse; 1990; 5(2):120-33. PubMed ID: 2137943
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Attenuation by electroconvulsive shock and antidepressant drugs of the 5-HT1A receptor-mediated hypothermia and serotonin syndrome produced by 8-OH-DPAT in the rat.
    Goodwin GM; De Souza RJ; Green AR
    Psychopharmacology (Berl); 1987; 91(4):500-5. PubMed ID: 2954178
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 5-HT1A receptors: differential involvement in female and male sexual behavior in the rat.
    Mendelson SD; Gorzalka BB
    Physiol Behav; 1986; 37(2):345-51. PubMed ID: 2942955
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Centrally coinjected galanin and a 5-HT1A agonist act synergistically to produce vasodepressor responses in the rat.
    Hedlund PB; Aguirre JA; Narvaez JA; Fuxe K
    Eur J Pharmacol; 1991 Oct; 204(1):87-95. PubMed ID: 1725157
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Region-selective inhibition of male rat sexual behavior and motor performance by localized forebrain 5-HT injections: a comparison with effects produced by 8-OH-DPAT.
    Hillegaart V; Ahlenius S; Larsson K
    Behav Brain Res; 1991 Feb; 42(2):169-80. PubMed ID: 1829365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.